Evidence map›Paper›PMID 31074545›Full record

ArticleHuman mutation2019

Using secondary structure to predict the effects of genetic variants on alternative splicing.

Robert Wang, Yaqiong Wang, Zhiqiang Hu

Abstract read
In one paragraph

Article in Human mutation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. In-silico Analysis ofInternational journal of molecular sciences · 2020
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Robert WangDepartment of Bioengineering, University of California, Berkeley, California.ORCID 0000-0003-2614-5956
Yaqiong WangDepartment of Plant and Microbial Biology, University of California, Berkeley, California.
Zhiqiang HuDepartment of Plant and Microbial Biology, University of California, Berkeley, California.ORCID 0000-0001-8854-3410

Funding

Sequencing of Newborn Blood Spot DNA to Improve and Expand Newborn ScreeningU19HD077627 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KOENIG, BARBARA A., KWOK, PUI-YAN · 2013 to 2018
$6.6M
Component 2 - Resource ProjectU41HG007346 · NHGRI · UNIVERSITY OF CALIFORNIA BERKELEY · PI BRENNER, STEVEN E · 2015 to 2017
$1.7M
Critical Assessment of Genome Interpretation ConferenceR13HG006650 · NHGRI · UNIVERSITY OF CALIFORNIA BERKELEY · PI BRENNER, STEVEN E · 2011 to 2018
$165k
NHGRI NIH HHS R13 HG006650NHGRI NIH HHS U41 HG007346NIHNIH HHS R13 HG006650NIH HHS U19 HD077627NIH HHS U41 HG007346NIH HHS U41 HG007446
6 · The paper itself

Abstract

Accurate interpretation of genomic variants that alter RNA splicing is critical to precision medicine. We present a computational framework, Prediction of variant Effect on Percent Spliced In (PEPSI), that predicts the splicing impact of coding and noncoding variants for the Fifth Critical Assessment of Genome Interpretation (CAGI5) "Vex-seq" challenge. PEPSI is a random forest regression model trained on multiple layers of features associated with sequence conservation and regulatory sequence elements. Compared to other splicing defect prediction tools from the literature, our framework integrates secondary structure information in predicting variants that disrupt splicing regulatory elements (SREs). We applied our model to classify splice-disrupting variants among 2,094 single-nucleotide polymorphisms from the Exome Aggregation Consortium using model-predicted changes in percent spliced in (ΔPSI) associated with tested variants. Benchmarking our model against widely used state-of-the-art tools, we demonstrate that PEPSI achieves comparable performance in terms of sensitivity and precision. Moreover, we also show that using secondary structure context can help resolve several cases where changes in the counts of SREs do not correspond with the directionality of ΔPSI measured for tested variants.

Indexed as

Alternative SplicingPolymorphism, Single NucleotideAnimalsComputational BiologyExome SequencingHumansProteinsProtein Structure, SecondaryRegression AnalysisRNA Splice SitesProteinsRNA Splice Sitesalternative splicingCAGIRNA secondary structuresplice-disrupting variantssplicing regulatory elements

Identifiers

PMID31074545
PMCPMC7288985

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.